Clinical trial

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT02555215

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-22

PhasePHASE3

Study timeline

Study start (actual)2016-02-22Date precision: day

Registry last updated2019-11-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

dimethyl fumarateDRUG · verified · RxNorm: dimethyl fumarate

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

SofiaBulgaria1 AnkaraTurkey (Türkiye)1 PoznanPoland1 GdanskPoland1 GhentBelgium1 RigaLatvia1 Loma LindaCalifornia, United States1 Hradec KrálovéCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02555215 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.